Summary
Erythritol was once the gold standard for sugar reduction—clean taste, low glycemic impact, functional bulk, and formulation flexibility. But tariffs, anti-dumping rulings, and mounting scientific scrutiny have dramatically altered its risk profile. With prices volatile and new research raising concerns about cardiovascular and metabolic implications
The Erythritol Reckoning, better-for-you brands can no longer afford to rely on erythritol as a default solution. The market is shifting toward diversified sweetening systems that incorporate allulose, functional fibers, high-intensity sweetener synergy, and modular formulation strategies. This isn’t panic—it’s recalibration. In this paper, we explore what’s changed, what it means for CPG formulators, and how to build adaptive, cost-resilient, label-friendly systems that protect both margins and consumer trust. In Part 2, we’ll go deeper into practical reformulation frameworks and real-world sweetener stack strategies designed for long-term flexibility.
Thom King, CFS, Food Scientist
Chief Innovations Officer, Icon Foods
Erythritol used to be the golden child of the polyol family—a low-calorie sweetener with a clean taste, functional bulk, excellent crystallization properties, and an enviable glycemic profile. It ticked all the boxes for clean label sugar reduction in the better-for-you space. For years, it cruised under the regulatory radar and avoided the stomach-churning baggage of some of its polyol cousins. It was, quite literally, the sweet spot.
But oh, how the tables have turned.
From Golden Child to Regulatory Whipping Boy
Let’s start with the tariff tantrum. As geopolitical tensions mounted and the U.S. sought to protect domestic manufacturing, erythritol — largely imported from China — found itself in the crosshairs. Tariffs jacked up prices. Predictable. But the real blow came with the U.S. International Trade Commission’s ruling in favor of Cargill’s anti-dumping petition. This effectively slapped both anti-dumping duties (ADD) and countervailing duties (CVD) on erythritol imports, driving prices up even further.
The irony? There’s no meaningful domestic production capacity to pick up the slack. So we’re punishing CPGs without offering a domestic alternative. The cost of erythritol is now flirting with the kind of volatility that gives CFOs migraines and sends formulators scrambling.
And Then Came the Science
Just as supply chain woes were straining erythritol’s economic viability, a flurry of scientific publications dropped like a cluster bomb on its health halo:
- Nature Medicine (2023): A study showing a correlation between elevated erythritol levels and increased risk of major adverse cardiovascular events (MACE).
- Science.org (2024): Follow-up analysis linked erythritol consumption with elevated platelet reactivity, which could prime the body for clot formation—especially problematic for individuals already at risk.
- Neurological Findings (2025): The latest study—still peer-review pending but already making waves—suggests that chronic erythritol consumption may affect cerebral glucose metabolism, possibly impacting cognition or neuroinflammation in predisposed populations.
Are these definitive? Not quite. Are they damning in the court of public opinion? Absolutely.
Where Does the Market Go From Here?
Erythritol’s fall from grace leaves a gaping hole in the formulation toolkit, especially for CPG brands banking on its low-calorie bulking, clean flavor, and compatibility with allulose, stevia, and monk fruit.
So now we ask: where does the market pivot?
Shift Toward Allulose
Allulose is already the heir apparent. It caramelizes. It depresses freezing point. It behaves like sugar in a Maillard reaction. And it doesn’t spike blood sugar. But… it’s not cheap. And it’s still riding out the rollercoaster of supply chain unpredictability and GRAS petition scrutiny in global markets (hello, EU).
Strategic Use of Fiber
Enter the polymer revolution. Soluble tapioca fiber, isomaltooligosaccharides, FOS, gum acacia, and partially hydrolyzed guar gum (shameless plug for FibRefine™ here) are stepping in to fill erythritol’s bulking shoes. They add body, contribute mild sweetness, and offer digestive benefits. Fiber stacking also keeps you below GI-triggering thresholds while boosting label appeal.
Embrace Sweetness Synergy
We’re seeing increased interest in stacking high-intensity sweeteners—like Reb M, Reb D, Mogroside V—with functional carriers and sweetness modulators like Thaumatin (ThauSweet™ VRM and DRM). This approach not only enhances sensory performance but smooths out aftertastes and builds cost-efficiency into the formula.
Formulate for Flexibility
Smart CPGs are now designing products with interchangeable sweetening systems—think modular formulations that allow for rapid pivoting based on pricing, availability, and public perception. If erythritol is available and affordable again? Plug it in. If not? Slot in an allulose/fiber blend.
The Icon Foods Perspective
We’ve always believed that resiliency in formulation comes from diversity of options and transparency in labeling. Icon Foods has long stocked multiple sweetening platforms—erythritol included—but we’ve also anticipated the need to diversify:
- Allulose? Check.
- Stevia & monk fruit blends? Dialed in.
- Soluble fibers for bulking and gut health? In stock.
- Sweetness modulators to optimize flavor? Already shipping.
This isn’t the end of erythritol—but it is a call to evolve. If you’re still relying on it as your primary tool, your cost of goods is about to become unsustainable, and your consumer trust may wobble.
The better-for-you market is undergoing a recalibration. It’s not just about fewer carbs and less sugar. It’s about clean labels, metabolic health, and adaptive formulation. Erythritol may not be gone, but it’s no longer the knight in sugar-free armor.
So to all the CPG brands out there: reformulate now, or risk being priced—and potentially regulated—out of the game.
At Icon Foods, we’ve got the solutions and the science to back them up. Let’s build your Plan B… before Plan A burns down.
Request Samples
